WASHINGTON (AP) -- Wall Street investors wanted clarity from Federal Reserve Chairman Ben Bernanke.
They didn't like it when they got it.
Bernanke set the record straight Wednesday about the Fed's bond-buying program. He said the Fed expects to scale back bond purchases later this year and end it entirely by mid-2014 if the economy continues to improve.
In response, investors dumped stocks and bonds in anticipation of rising interest rates.
The Fed has been buying $85 billion worth of Treasury and mortgage bonds a month since late last year. The purchases pushed long-term rates to historic lows, fueled a record-breaking stock market rally, encouraged consumers and businesses to borrow and spend and provided a crutch to an economy hobbled by federal tax hikes and spending cuts.
Confusion about the central bank's intentions set in last month after the Fed released a summary of its April 30-May 1 meeting: Several Fed policymakers said they were open to reducing the bond purchases as early as this week's meeting.
Top Cheap Companies To Own For 2015: Centene Corporation (CNC)
Centene Corporation provides multi-line healthcare programs and services in the United States. It operates in two segments, Medicaid Managed Care and Specialty Services. The Medicaid Managed Care segment provides Medicaid and Medicaid-related health plan coverage to individuals through government subsidized programs, including Medicaid, the State children�s health insurance program, long-term care, foster care, and Medicare special needs plans, as well as aged, blind, or disabled programs. Its health plans provide primary and specialty physician care, inpatient and outpatient hospital care, transportation assistance, emergency and urgent care, vision care, prenatal care, dental care, laboratory and x-ray services, immunizations, prescriptions and over-the-counter drugs, home health and durable medical equipment, behavioral health and substance abuse services, therapies, social work services, care coordination, and 24-hour nurse advice line. The Specialty Services segment manages behavioral healthcare for members; provides health insurance to individual customers and their families; implements life and health management programs; offers long-term care services to the elderly and people with disabilities; and administers routine and medical surgical eye care benefits through its network of eye care providers. It also offers telehealth services; and claims processing, pharmacy network management, benefit design consultation, drug utilization review, formulary and rebate management, specialty and mail order pharmacy services, and patient and physician intervention services, as well as provides care management solutions that automate the clinical, administrative, and technical components of care management programs. The company offers its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
Advisors' Opinion:- [By Omar Venerio]
The company has a current ROE of 10.94% which is higher than the industry median and the ones exhibit by Universal American Corp. (UAM), Centene (CNC) and WellPoint (WLP). In general, analysts consider ROE ratios in the 15-20% range as representing attractive levels for investment. So for investors looking those levels or more, Cigna (CI) could be the option. It is very important to understand this metric before investing and it is important to look at the trend in ROE over time.
- [By Jake L'Ecuyer]
Shares of Centene (NYSE: CNC) got a boost, shooting up 12.72 percent to $64.58 on upbeat quarterly results. Centene reported its Q1 earnings of $0.57 per share on revenue of $3.46 billion.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Centene (NYSE: CNC ) , whose recent revenue and earnings are plotted below. - [By Holly LaFon]
Importantly, we like the industry in which Centene (CNC) competes. Some of our investors might recall that one of our prior investments, Amerigroup, was acquired in 2012 by Wellpoint at a val uation that allowed us to achieve a return on investment of greater than 100% over the roughly one - year time period that we owned the shares. Medicaid managed care companies not only save states money but also offer better service; therefore, more states a re letting managed care companies run their Medicaid programs. To that end, states are expanding both the geographies carved out to managed care companies and the types of programs. The next phase of growth will come from the dual - eligible population. D uals (or dual - eligible population) are 8.3mm 3 people in the U.S. that are eligible to receive both Medicare and Medicaid benefits (mainly low - income seniors). According to the Kaiser Foundation, Duals accounted for almost 40% of Medicaid spending although they made up only 15% of the Medicaid population. We believe there are ample growth opportunities for CNC and other companies to meet the challenges of managing these disparate Medicaid members for the foreseeable future.
10 Best Rising Stocks To Buy Right Now: Rosetta Genomics Ltd (ROSG)
Rosetta Genomics Ltd., incorporated on March 9, 2000, is seeking to develop and commercialize diagnostic tests based on discovered group of genes known as microRNAs. The Company has established a clinical laboratory improvement amendment (CLIA)-certified laboratory in Philadelphia, which enables it to develop, validate and commercialize its own diagnostic tests applying its microRNA technology. In July 2011, the Company launched its fifth product - miRview lung. As of December 31, 2011, the Company launched five tests based on its five microRNA technologies: miRview mets; miRview mets2; miRview squamous; miRview meso, and miRview lung.
Rimonim Consortium
In January 2011, the Company joined the Rimonim Consortium, which is supported by the Office of the Chief Scientist at the Ministry of Industry, Trade and Labor of the State of Israel, or the OCS. The purpose of the consortium is to develop RNA interference, or RNAi, -based therapeutics.
Rosetta Green
Rosetta Green Ltd. is an Israeli subsidiary of the Company, which was established to leverage its capabilities into the areas of cleantech and plant biotech by using its microRNA technologies to develop plants and algae more suitable for various applications, such as feedstocks for biofuels and agriculture. Research at the Rosetta Green project has been shown to develop algal strains with oil content, to discover potential novel microRNAs from commercially-important algae and to identify drought-regulated microRNAs in plants.
The Company competes with Pathwork Diagnostics, Inc., Biotheranostics, Inc., Combimatrix Corporation, Alnylam Pharmaceuticals, Inc., Asuragen Inc., Exiqon A/S, Life Technologies Corporation, Isis Pharmaceuticals, Merck & Co., Inc., Santaris Pharma A/S, and Regulus Therapeutics.
Advisors' Opinion:- [By John Udovich]
The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer with the overall costs of the disease topping $126 billion annually ��meaning there is a big market for small cap cancer diagnostic stocks like Rosetta Genomics Ltd. (NASDAQ: ROSG), Genetic Technologies Limited (NASDAQ: GENE) and MetaStat Inc (OTCBB: MTST) just in the US alone without considering global cancer figures. After all, catching and doing something about cancer early on is critical to increase survival rates and bring down the cost of treatment. With that in mind, here are three small cap cancer diagnostic stocks helping to lead the fight to diagnose and stop cancer:
- [By John Udovich]
On Tuesday, small cap cancer diagnostic stock Myriad Genetics, Inc (NASDAQ: MYGN) jumped 11.42% in one day, meaning its worth taking a closer look at the stock along with the performance of small cap cancer diagnostic stocks like Rosetta Genomics Ltd (NASDAQ: ROSG) and�Genomic Health, Inc (NASDAQ: GHDX) plus mid cap diagnostic stock Quest Diagnostics Inc (NYSE: DGX). I should mention that we have had�Myriad Genetics in our SmallCap Network Elite Opportunity (SCN EO) portfolio since February 5th and we are already up 18.50%���a nice return in just two weeks time.
- [By John Udovich]
Small cap genomics stocks Rosetta Genomics Ltd (NASDAQ: ROSG), Genomic Health, Inc (NASDAQ: GHDX) and CollabRx Inc (NASDAQ: CLRX) are at the forefront of genomics testing�or research. I should mention that Wikipedia defines genomics�as a�discipline in genetics that applies recombinant DNA, DNA sequencing methods and bioinformatics to sequence, assemble and analyze the function and structure of genomes (the complete set of DNA within a single cell of an organism). A 2013 Booz Allen Hamilton report on the sector noted that in�2011, the US genetic and genomic clinical testing market size was estimated to be $5.9 billion while the�number of available tests has grown substantially from 1,680 just 4 years ago to 2,886 in 2012.
10 Best Rising Stocks To Buy Right Now: iShares U.S. Medical Devices ETF (IHI)
iShares Dow Jones U.S. Medical Devices Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Medical Equipment Index (the Index). The Index measures the performance of the medical equipment sector of the United States equity market. The Index includes medical equipment companies, such as manufacturers and distributors of medical devices, such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, x-ray machines and other non-disposable medical devices.
The Fund will concentrate its investments in a particular industry or group of industries to approximately the same extent as the Index is so concentrated. Since all of the securities included in the Index are issued by companies in the medical equipment sector, the Fund will be concentrated in the medical equipment industry. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By John Udovich]
On Thursday, small cap medical device stock Integra Lifesciences Holdings Corp (NASDAQ: IART) jumped 9.90% after the FDA completed its inspection of the company's manufacturing facility which led to positive comments from analysts, meaning it might be time to take a look at its performance verses that of medical device ETFs like iShares Dow Jones US Medical Device ETF (NYSEARCA: IHI) and SPDR S&P Health Care Equipment ETF (NYSEARCA: XHE).
10 Best Rising Stocks To Buy Right Now: Bumi Resources Tbk PT (BUMI)
PT Bumi Resources Tbk is an Indonesia-based company engaged in exploration and exploitation of coal deposits, including coal mining, and oil exploration. It also owns gold, iron, ore, zinc, lead and copper mines thorugh its subsidiaries. The Company and its subsidiaries classify their products and services into four core business segments: coal mining, services, oil and gas, and gold. The coal mining activities comprise exploration and exploitation of coal deposits, including mining and selling coal. The activity of services represents marketing and management services. The activity of gold, oil and gas are still under exploration stage. Advisors' Opinion:- [By Inyoung Hwang]
GlaxoSmithKline Plc (GSK) was the biggest drag on the benchmark measure after an executive said some employees may have broken the law in China. Bumi (BUMI) Plc tumbled 8.6 percent after the coal producer at the center of an ownership dispute ended a three-month halt in London trading. Fresnillo Plc and Randgold Resources Ltd. each added at least 3 percent as gold and silver rallied for a third day.
10 Best Rising Stocks To Buy Right Now: Spdr Dj Wilshire Small Cap Etf (SLY)
SPDR DJ Wilshire Small Cap ETF (the Fund), formerly streetTRACKS DJ Wilshire Small Cap ETF, seeks to replicate as closely as possible the total return of the Dow Jones Wilshire Small Cap Index (the Index). The Index is a float-adjusted market capitalization weighted index that reflects the shares of securities of the small-cap portion of the Dow Jones Wilshire 5000 Composite Index actually available to investors in the marketplace. The Index includes the components ranked 751 to 2,500 by full market capitalization. The Index consists of common stocks selected for their capitalization. The composition of the Index is reviewed semiannually in March and December. Shares and float factors of the Index are updated on a quarterly basis.
The Fund utilizes a passive or indexing approach and attempts to approximate the investment performance of its Index, by investing in a portfolio of stocks intended to replicate the Index. The Fund�� investment manager is SSgA Funds Management, Inc.
Advisors' Opinion:- [By Dan Caplinger]
Where the best gains are
The SPDR S&P 500 ETF (NYSEMKT: SPY ) weighs in with 20% gains with its exposure to 500 of the largest companies in the U.S. market. When you step down to mid-cap stocks, though, you'll get even better returns, with the SPDR S&P MidCap 400 ETF (NYSEMKT: MDY ) posting returns of 21% so far in 2013, based on the performance of 400 mid-sized companies domestically. The smallest companies in the market have done better still, as the SPDR S&P SmallCap 600 ETF (NYSEMKT: SLY ) has given investors impressive 24% returns since Jan. 1.
In fact, when you compare returns across stocks of various sizes, you'll get some surprising results:Why are smaller companies outperforming the largest stocks in the market? Historically, smaller stocks have posted better long-term returns than their larger counterparts, with theoreticians pointing to the greater risk involved in small-cap stocks as justifying the higher risk premium that investors should demand in order to hold them over the long run.
- [By Will Ashworth]
By the time the dust settled in 2013, small caps won the day (well, year) — the SPDR S&P SmallCap 600 (SLY) had outperformed the SPDR S&P 500 ETF (SPY) by almost 9 percentage points.
10 Best Rising Stocks To Buy Right Now: Iliad SA (ILD)
Iliad SA is a France-based holding company active in the integrated telecommunications sector. The Company provides Internet access services, hosting services and others. Iliad SA is also focused on fixed-line telephony services and the provision of wireless fidelity (WiFi) cards, among several others. In addition, Iliad SA sells via Internet a range of insurance policies. As of December 31, 2012, the Company had a number of subsidiaries, which include Free SAS, Centrapel SAS, Freebox SAS, Telecom Academy SARL, Free Frequences SAS, Iliad 1 SAS, Iliad 2 SAS, Protelco SAS, IFW SAS, IRE SAS, Management Centre De Relation Abonne (MCRA), F Distribution SAS, and Centrapel SAS, among others. Its Fixe subsidiary is a landline business-provider of broadband Internet services. As of year-end 2012, the Company was active as a operator in more than 35 countries. Advisors' Opinion:- [By Marie Mawad]
Sales and earnings at Orange are falling as domestic competition with rivals including discounter Iliad SA (ILD) weighs on prices. The carrier, which has diversified into countries from Poland to Egypt, is also trying to keep a lid on debt.
- [By Patricio Kehoe]
In order to counter the aggressive pricing strategy from wireless new entrant Iliad SA (ILD) in France, Orange was forced to reduce prices. Thus, the firm has continued to add wireless subscribers but at a lower average revenue per user, mainly through its low-end Sosh brand.
10 Best Rising Stocks To Buy Right Now: Healthcare Services Group Inc. (HCSG)
Healthcare Services Group, Inc., through its subsidiaries, provides housekeeping, laundry, linen, facility maintenance, and food services to nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates in two segments, Housekeeping, Laundry, Linen, and Other services (Housekeeping); and Dietary Department Services (Dietary). The Housekeeping segment offers cleaning, disinfecting, and sanitizing of patient rooms, and areas of client?s facility, as well as laundering and processing of the personal clothing belonging to the facility?s patients. It also engages in laundering and processing bed linens, uniforms, and other assorted linen items utilized by client?s facility, as well as distributes laundry installations. In addition, this segment provides maintenance services that consist of repair and maintenance of laundry equipment, plumbing, and electrical systems, as well as carpentry and painting services. The Dietary segment i nvolves in providing dietician consulting professional services, developing a menu that meets the patient?s dietary needs, and purchasing and preparing the food for delivery to the patients, as well as participates in monitoring the residents? on-going nutritional status through providing dietician consulting professional services. As of December 31, 2009, the company provided services to approximately 2,300 facilities in 47 states. Healthcare Services Group was founded in 1976 and is based in Bensalem, Pennsylvania.
Advisors' Opinion:- [By Seth Jayson]
There's no foolproof way to know the future for Healthcare Services Group (Nasdaq: HCSG ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.
No comments:
Post a Comment